More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

A project at the cutting edge of cancer research hopes to build a collection of tiny lab-grown tumours at the University of ...

A Northampton County attorney facing charges in two drug cases was sent to prison Monday because he refused to submit a urine sample for a drug test.

Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, from technology that preserves donor tissue longer to treatments that redu ...

The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.

A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in a Phase 2 trial, one analyst said.

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

A Texas man has accused a California doctor of prescribing abortion pills to his partner in violation of state law, in what ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Scientists engineered dissolving needle patches with microscopic bubbles that deliver three acne drugs at once, vanishing in ...

For the first time, a jury will hear claims that social media giants like Meta designed social media to addict young users.